FGF19 amplification was independently associated with shorter survival and a higher risk of recurrence in patients with HCC, and was correlated with poor prognostic factors such as high α-fetoprotein and microvascular invasion [73] (Figure 1(6c)). The gene discussed is FGF19; the disease is hepatocellular carcinoma.